Loading news...
Encompass Health (NYSE: EHC - Get Free Report) and Bioqual (OTCMKTS:BIOQ - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings. Profitability This table compares Encompass Health and Bioqual's net
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pink Limited): Three Months Ended August 31, 2025 2024 Revenue $ 9,855,399 $ 11,770,482 Loss Before Income Tax $ (343,432 ) $ (931,825 ) Net Loss $ (248,832 ) $ (675,325 ) Basic Earnings per Share of Common Stock $ (0.28 ) $ (0.76 ) Diluted Earnings per Share of Common Stock $ (0.28 ) $ (0.76 ) Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 89.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets): 2025 2024 Revenue $ 48,867,753 $ 58,590,949 (Loss) Income Before Income Tax $ (1,896,010 ) $ 476,447 Net (Loss) Income $ (1,048,154 ) $ 483,481 Basic Earnings per Share of Common Stock $ (1.17 ) $ .54 Diluted Earnings per Share of Common Stock $ (1.17 ) $ .54 Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 894,416 Weighted Average.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets): Dr. Mark Lewis will be retiring as President of BIOQUAL effective May 31, 2025, and is succeeded by Dr. Hanne Andersen Elyard, BIOQUAL's Chief Science Officer. Dr. Lewis will remain as Chairman of the Board of Directors. Dr. Lewis joined BIOQUAL as Senior Scientist in August 2003. He became the Executive Vice President in October 2008 and served in that capacity until he became President and CEO in 2010. “The entir.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets) BIOQUAL, Inc., announced today that Mr. Michael P. O'Flaherty will retire from his role as a BIOQUAL Board Member effective May 1, 2025. Mr. O'Flaherty served as the Chief Operating Officer and Secretary of the Corporation until he retired in 2015 at which time he was elected to the BIOQUAL Board. Mr. O'Flaherty is 86 years old and has served as a Director since 2015. His retirement is not connected to any disagreem.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com: Nine Months Ended Three Months Ended February 28 & 29, February 28 & 29, 2025 2024 2025 2024 Revenue $ 37,198,902 $ 46,792,353 $ 14,032,982 $ 15,344,027 (Loss) Income Before Income Tax $ (1,312,897 ) $ 2,288,970 $ 1,291,330 $ 379,226 Net (Loss) Income $ (951,497 ) $ 1,659,170 $ 936,030 $ 275,026 Basic Earnings per Share of Common Stock $ (1.06 ) $ 1.86 $ 1.05 $ 0.31 Dil.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com: Six Months Ended Three Months Ended November 30, November 30, 2024 2023 2024 2023 Revenue $ 23,165,920 $ 31,448,326 $ 11,395,438 $ 15,869,404 (Loss) Income Before Income Tax $ (2,604,227 ) $ 1,909,744 $ (1,672,402 ) $ 668,561 Net (Loss) Income $ (1,887,527 ) $ 1,384,144 $ (1,212,202 ) $ 484,661 Basic Earnings per Share of Common Stock $ (2.11 ) $ 1.55 $ (1.36 ) $ 0.54 Dilut.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com: Three Months Ended August 31, 2024 2023 Revenue $ 11,770,482 $ 15,578,922 Income (Loss) Before Income Tax $ (931,825 ) $ 1,241,183 Net Income (Loss) $ (675,325 ) $ 899,483 Basic Earnings per Share of Common Stock $ (0.76 ) $ 1.01 Diluted Earnings per Share of Common Stock $ (0.76 ) $ 1.01 Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 894,416 .
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL's Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 7, 2024, payable on October 28, 2024. This is the twenty-third dividend declared by BIOQUAL. Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statem.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com: 2024 2023 Revenue $ 58,590,949 $ 62,663,804 Income Before Income Tax $ 476,447 $ 1,133,242 Net Income $ 483,481 $ 835,548 Basic Earnings per Share of Common Stock $ .54 $ .93 Diluted Earnings per Share of Common Stock $ .54 $ .93 Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 894,416 Weighted Average Number of Shares Outstanding For Diluted E.
ROCKVILLE, Md.--(BUSINESS WIRE)--This week BIOQUAL, Inc. (OTC: BIOQ) announced a reduction in workforce (RIF) of approximately 10% of its employees effective Monday, September 9, 2024. The RIF was a necessary cost-cutting measure due to the decrease in revenue and profitability that BIOQUAL has experienced in the last year. In a post-COVID-19 environment, the Company has seen a significant drop in the demand for their services due to the development of COVID-19 vaccines and therapeutics and nee.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com: Nine Months Ended Three Months Ended February 29 & 28, February 29 & 28, 2024 2023 2024 2023 Revenue $ 46,792,353 $ 46,595,270 $ 15,344,027 $ 14,107,568 Income Before Income Tax $ 2,288,970 $ 2,174,295 $ 379,226 $ (1,610,199 ) Net Income $ 1,659,170 $ 1,537,695 $ 275,026 $ (1,139,699 ) Basic Earnings per Share of Common Stock $ 1.86 $ 1.72 $ 0.31 $ (1.27 ) Diluted Earnings per Share of Com.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL presents unaudited financial results for second quarter of fiscal year 2024.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink:BIOQ) www.bioqual.com: Three Months Ended August 31, 2023 2022 Revenue $ 15,578,922 $ 15,810,574 Income Before Income Tax $ 1,241,183 $ 1,955,660 Net Income $ 899,483 $ 1,383,560 Basic Earnings per Share of Common Stock $ 1.01 $ 1.55 Diluted Earnings per Share of Common Stock $ 1.01 $ 1.55 Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 894,416.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL's Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 6, 2023, payable on October 27, 2023. This is the twenty-second dividend declared by BIOQUAL. Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking state.
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink:BIOQ) www.bioqual.com: 2023 2022 Revenue $ 62,663,804 $ 66,150,373 Income Before Income Tax $ 1,133,242 $ 6,576,784 Net Income $ 835,548 $ 5,260,569 Basic Earnings per Share of Common Stock $ .93 $ 5.88 Diluted Earnings per Share of Common Stock $ .93 $ 5.88 Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 894,416 Weighted Average Number.